Back to available technologies

Search our Available Technologies

By Clinical Application > Blood & Lymphatic Disease

A method for predicting the responsiveness of lymphomas to PI3K pathway inhibitors

Value Proposition Lymphomas are highly diverse and among the most...


MEK inhibitors as therapeutic agents and diagnostic tools for hemoglobinopathies, including thalassemia

Value Proposition Patients with sickle cell disease experience acute vaso-occlusive...